↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$19.3MSold on the market
1Companies
Oct 8, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202619:56 | Oct 8, 2026from Oct 6, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | S · Sell10b5-1 | $110.18 | −60,000 | 767,780 | -7% | −$6.6M | ||
| Oct 8, 202619:56 | Oct 8, 2026from Oct 6, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | M · Exercise10b5-1 | $18.41 | +60,000 | 787,780 | +8% | $1.1M | ||
| Sep 11, 202620:35 | Sep 11, 2026from Sep 9, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | S · Sell10b5-1 | $107.28 | −60,000 | 767,780 | -7% | −$6.4M | ||
| Sep 11, 202620:35 | Sep 11, 2026from Sep 9, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | M · Exercise10b5-1 | $18.41 | +60,000 | 787,780 | +8% | $1.1M | ||
| Aug 19, 202620:01 | Aug 19, 2026from Aug 17, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | S · Sell10b5-1 | $104.59 | −60,000 | 767,780 | -7% | −$6.3M | ||
| Aug 19, 202620:01 | Aug 19, 2026from Aug 17, 2026 | HALOHALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO, Director | M · Exercise10b5-1 | $18.41 | +60,000 | 787,780 | +8% | $1.1M |